SWP
AMED

Sagespring Wealth Partners’s Amedisys AMED Stock Holding History

Sagespring Wealth Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,860
Closed -$380K – 734
2025
Q2 		$380K Buy
3,860
+623
+19% +$58.9K 0.01% 511
2025
Q1 		$300K Buy
3,237
+354
+12% +$32.6K 0.01% 517
2024
Q4 		$262K Buy
+2,883
New +$265K 0.01% 510

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sagespring Wealth Partners's AMED Position: Q3 2025 in Review

Sagespring Wealth Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,860 shares — an estimated $380K sold.

Sagespring Wealth Partners first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $380K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Sagespring Wealth Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Sagespring Wealth Partners sold 3,860 Amedisys shares in Q3 2025, an estimated $380K.
  • Sagespring Wealth Partners first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
  • Sagespring Wealth Partners's Amedisys position peaked at $380K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Sagespring Wealth Partners's 13F filing for Q3 2025, filed 31 Oct 2025.